Next Article in Journal
Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer’s Disease: Synthesis, Docking and Biological Evaluation
Next Article in Special Issue
Modulating the Blood–Brain Barrier: A Comprehensive Review
Previous Article in Journal
Ceftriaxone Mediated Synthesized Gold Nanoparticles: A Nano-Therapeutic Tool to Target Bacterial Resistance
Previous Article in Special Issue
Blood–Brain Barrier Permeability: Is 5-Hydroxytryptamine Receptor Type 4 a Game Changer?
 
 
Review

Article Versions Notes

Pharmaceutics 2021, 13(11), 1897; https://doi.org/10.3390/pharmaceutics13111897
Action Date Notes Link
article xml file uploaded 8 November 2021 15:00 CET Original file -
article xml uploaded. 8 November 2021 15:00 CET Update https://www.mdpi.com/1999-4923/13/11/1897/xml
article pdf uploaded. 8 November 2021 15:00 CET Version of Record https://www.mdpi.com/1999-4923/13/11/1897/pdf
article html file updated 8 November 2021 15:02 CET Original file -
article html file updated 30 July 2022 15:32 CEST Update https://www.mdpi.com/1999-4923/13/11/1897/html
Back to TopTop